Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Biotransformation in liver damage].

D Jorke1, A Hoffmann, G Machnik

  • 1Klinik Innere Medizin, Bereichs Medizin der Friedrich-Schiller-Universität Jena, DDR.

Gastroenterologisches Journal : Organ Der Gesellschaft Fur Gastroenterologie Der DDR
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mediator release assays based on human or murine immunoglobulin E in allergen standardization.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2007
Same author

[Retained foreign bodies from the surgical point of view].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2006
Same author

Bulk chemical shifts in hydrogen-bonded systems from first-principles calculations and solid-state-NMR.

The journal of physical chemistry. B·2006
Same author

Transcriptional regulation via the NF-kappaB signaling module.

Oncogene·2006
Same author

Fast variability of tera-electron volt gamma rays from the radio galaxy M87.

Science (New York, N.Y.)·2006
Same author

Comment on "Photoemission study of YBa(2)Cu(3)O(y) thin films under light illumination".

Physical review letters·2006
Same journal

[Gastric and duodenal polyps in acromegaly].

Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR·1991
Same journal

[Clinical, infrared spectroscopic and chemical analysis of bile duct and gallbladder stones].

Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR·1991
Same journal

Secretin provocation ultrasonography in the diagnosis of papillary obstruction in pancreas divisum.

Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR·1991
Same journal

[Prognostic parameters in peptic ulcer disease].

Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR·1991
Same journal

[Influence of the ileum on the regulation of gastrointestinal motility].

Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR·1991
Same journal

[The effects of verapamil and nifedipine on the biotransformation of model substances and on the indocyanine green elimination].

Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR·1991
See all related articles

Liver diseases can impair drug metabolism and elimination, affecting how the body processes medications. Severe liver conditions significantly reduce drug biotransformation, impacting treatment efficacy.

Area of Science:

  • Pharmacology and Toxicology
  • Hepatology
  • Drug Metabolism

Context:

  • Xenobiotics can cause liver damage, and conversely, primary liver diseases alter drug metabolism and elimination.
  • The liver's monooxygenase system (cytochrome P450 isoenzymes) metabolizes drugs, and its activity can be modulated by factors like hormones, smoking, and alcohol.
  • Severe liver diseases, such as cirrhosis, notably reduce drug biotransformation.

Purpose:

  • To investigate the relationship between liver diseases and drug biotransformation processes.
  • To assess how liver damage affects the activity of key drug-metabolizing enzymes.
  • To correlate specific liver pathologies with alterations in drug metabolism and elimination.

Summary:

  • Liver diseases can significantly impair drug metabolism, with severe conditions like cirrhosis leading to increased excretion of unchanged drugs (e.g., furosemide) and altered bioavailability (e.g., propranolol).

Related Experiment Videos

  • Genetic factors (slow acetylators) and conditions like drug hepatitis and hemochromatosis are associated with reduced Phase I cytochrome P450 activity.
  • Measuring 7-ethoxycoumarin-O-deethylase (ECOD) in liver biopsies can link decreased biotransformation to liver cell necrosis, fibrosis, and structural damage, potentially related to impaired liver regeneration ('streaming liver' concept).

    • Impact:

    • Highlights the critical role of liver function in drug efficacy and safety.
    • Provides insights into personalized medicine approaches by considering liver health and genetic predispositions in drug therapy.
    • Suggests potential links between drug metabolism dysfunction, liver pathology, and regenerative processes in liver disease.